Reuters logo
BRIEF-Helix Biopharma signs LOI with Ken Poland
February 22, 2017 / 12:49 PM / 7 months ago

BRIEF-Helix Biopharma signs LOI with Ken Poland

Feb 22 (Reuters) - Helix Biopharma Corp:

* Helix Biopharma Corp - signed non-binding loi with ken poland in support of European centre for cancer immunotherapy

* Helix Biopharma-LOI contemplates proposed investment by Ken Poland of about $30 million Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below